OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production leverages Chinese hamster ovary (CHO) cells due to their robustness in expressing complex molecules. Optimizing these processes involves modifying various variables, including cell line development, media composition, and bioreactor environments. A key goal is to amplify antibody yield while lowering production expen